Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

SCD1 inhibitors can cause skin issues in rodents.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Reducing nerve growth can help skin regenerate after birth.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

JAK inhibitors may reduce depression in people with alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Pharmacists play a crucial role in patient education and personalized care.